Fatigue News and Research

RSS

New NCCN Guidelines for Smoking Cessation published

Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States--more than 25 percent--will be caused by tobacco smoking.

16 Mar 2015

Blunted cortisol response common in non-classic CAH

Nearly two-thirds of children with non-classic congenital adrenal hyperplasia have an inadequate cortisol response, report researchers.

13 Mar 2015

Good night, sleep tight...or will you?

World Sleep Day is organized by the World Association of Sleep Medicine (WASM) to spread awareness of important sleep-related issues through a series of special events. This year it is focussing on insomnia with the theme “When Sleep is Sound, Health and Happiness Abound”.

13 Mar 2015

Tablet use has implications for potential neck injury

Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.

13 Mar 2015

Study shows fatigue pathways are more sensitive in patients with chronic fatigue syndrome

The mechanism that causes high-performance athletes to "feel the burn" turns out to be the culprit in what makes people with chronic fatigue syndrome feel exhausted by the most common daily activities, new University of Florida Health research shows.

13 Mar 2015

In-car alarm could reduce crashes for young and old drivers

An in-car alarm that sounds when sensors on the vehicle detect an imminent crash could cut crash rates from 1 in 5 to 1 in 10 for drivers over the of 60 suffering tiredness on long journeys, according to a study published in the International Journal of Human Factors and Ergonomics.

11 Mar 2015

Researchers find that weight-loss strategies sorely lacking for individuals with neurological disabilities

A review of nutrition and weight-loss interventions for people with impaired mobility found strategies are sorely lacking for people with neurological disabilities, according to a team of researchers from Case Western Reserve University and Cleveland Clinic.

10 Mar 2015

New patient-centered mobile app launched for breast cancer patients

Apple and Sage Bionetworks, together with UCLA cancer research pioneer and collaborator Dr. Patricia Ganz, today announced the launch of Share the Journey: Mind, Body and Wellness after Breast Cancer, a patient-centered mobile app that empowers women to be partners in the research process by tracking their symptoms and successes.

10 Mar 2015

Researchers use stem cells from sickle cell disease patients to grow mature red blood cells

Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.

10 Mar 2015

Depression symptoms under-recognized in African-American cancer patients

Case Western Reserve University nurse scientist Amy Zhang, who has long examined quality-of-life issues in cancer patients, wondered whether depression in African-American cancer patients has been under-recognized for treatment.

10 Mar 2015

Using IT devices may put your muscles and joints under particular strain

Spending hours on a computer or sending lots of text messages on a mobile phone can result in a stiff neck and sometimes even a strained thumb. Computer scientists in Saarbrücken have developed a procedure that simulates in a lifelike manner which muscles and joints are put under particular strain when using IT devices. It also demonstrates the speed and accuracy with which a user can operate a device.

10 Mar 2015

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

CTI BioPharma Corp. and Baxter International Inc. today announced positive top-line results for the primary endpoint from PERSIST-1, the randomized, controlled Phase 3 registration clinical trial examining pacritinib, a next generation oral JAK2/FLT3 multikinase inhibitor, for the treatment of patients with primary or secondary myelofibrosis.

From Baxter International Inc. 9 Mar 2015

DePaul University experts available to discuss different health care topics

With the fifth anniversary of the presidential signing of the U.S. Affordable Care Act March 23, faculty experts from DePaul University are available to discuss a range of health care topics including the analysis of health care data, community health, patient experience, communication among health care professionals, interprofessional health care education and the role of nurses and physician assistants.

6 Mar 2015

Study shows heart valve repair can benefit patients with mitral regurgitation

Patients with severe mitral regurgitation (MR) often suffer from psycho-emotional symptoms, such as depression and anxiety, but after undergoing mitral valve repair surgery patients experience a marked improvement in emotional and physical wellbeing, according to an article in the March 2015 issue of The Annals of Thoracic Surgery.

2 Mar 2015

Routledge Journals' new special issue focuses on CFS, ME/CFS and ME research

Routledge Journals is pleased to announce a new Special Issue from the Journal of Prevention & Intervention in the Community exploring topics and constructs that could help clarify uncertainties surrounding Chronic Fatigue Syndrome (CFS), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), or Myalgic Encephalomyelitis (ME) research.

28 Feb 2015

Indiana University study reveals connection between mussels and muscles

An Indiana University study has revealed that there may be a greater connection between mussels and muscles than previously thought.

25 Feb 2015

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.

24 Feb 2015

Smartphones, tablets can do damage to overall health in unexpected ways

Despite the many benefits of having information at your fingertips, smartphones and tablets can do damage to your body and overall health in unexpected ways.

21 Feb 2015

Novartis’ heart failure medicine LCZ696 granted FDA priority review

LCZ696, a twice-a-day medicine being investigated for heart failure, acts to enhance the protective neurohormonal systems of the heart (NP system) while simultaneously suppressing the harmful effects of the overactive renin-angiotensin-aldosterone system (RAAS).

16 Feb 2015

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Hospira, Inc., a world leader in the development of biosimilar therapies, today announced the launch of the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European markets.

16 Feb 2015